Biopsys Medical Inc. commences initial public offering of common stock.IRVINE, Calif.--(BUSINESS WIRE)--May 1, 1996--Biopsys Medical Inc. (the company) announced today that it has made an initial public offering of 2,250,000 shares of its common stock. All of the shares are being sold by Biopsys Medical Inc. The initial public offering price was $15 per share. The offering is being managed by Robertson, Stephens & Co. LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution Inc. The net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). to the company from the offering will be used to expand sales and marketing activities, increase manufacturing capabilities and fund research and development, with the remainder to be used for working capital and general corporate purposes. Biopsys Medical Inc. designs, develops, manufactures and markets products for the diagnosis and management of breast cancer. The company's principal product, the Mammotome Biopsy System, is a less-invasive alternative to open surgical biopsy. The Mammotome Biopsy System allows women, who might otherwise have undergone open surgery, to receive a non-surgical biopsy on an outpatient basis. The company received 510(k) clearance to market the Mammotome Biopsy System from the United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. in April 1995 and commenced commercial sales in August 1995. Copies of the prospectus relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the offering may be obtained from Robertson, Stephens & Company LLC, 555 California Street, Suite 2600, San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , Calif. 94104, Attention: Prospectus Department, 415/781-9700; or Piper Jaffray Inc., 222 South Ninth Street, Minneapolis, MN, 55402-3804, 612/342-6000. CONTACT: Biopsys Medical Inc. Steven J. Naber, 714/460-7815, ext. 325 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion